factual
Regulation certifies effectiveness, not comparative value
The FDA and Medicare do not legally evaluate whether a treatment is worth its cost; certification only requires showing a treatment is medically effective, often against a placebo rather than against the next-best existing drug (the opportunity cost), so treatments get approved and covered without any comparison establishing whether they are cost-effective or better than cheaper alternatives.
factualpending
Speaker
Jonathan SkinnerEvidence Quote
“they are not asked to actually compare whether this one is any better... I don't think that the regulatory structure in the United States is set up to make these kinds of comparisons, to say, 'Yes, this is cost effective, and this isn't.'”
Created: 6/13/2026, 12:21:47 AM
Your notes
Loading notes...